RE:Like I said, FUDsters working overtimeFrom the call,
They were very clear.
details of both MBc & pancreatic phase 3 trials will be presented THIS QUARTER.
meaning within next 5-6 weeks.
The fda meeting has been granted. While they did not give exact day or time. They said has been granted & will be in this quarter.
since, they can not afford a phase 3 without a partner, logical progression?
1. details from FDA.
2.:partership with Roche/ pfuzer or other to describe start of phase 3 mbc
soecisl note.
Once the FDA trial details are colated & released. The China partner will be able to start their phase three, ASAP.
triggering milestone payments.
last , very subtle, but very important.
They are looking to pre- design a MBc trial , with appropriate results leading to direct product approval.
on the pancrestic side?
They are aiming for & predict Pelareorep to be standard of care , for a very broad range of pancreatic cancers.
The call is recorded. I recommend people listen in for yourself.
dont take my word.
Obviously no partership yet.
however , all indications point to that being announced soon after the FDA meeting results are made public.